Instalab

BMD T Score (Right Femoral Neck)

Test
The clearest read on your hip fracture risk, before a fall reveals it.

Should you take a BMD T Score (Right Femoral Neck) test?

This test is most useful if any of these apply to you.

Going Through or Past Menopause
Estrogen loss accelerates bone breakdown, and your hip is where it shows up first. A baseline now sets the trend for the next 30 years.
With a Family History of Hip Fracture
Hip fragility runs in families. A scan tells you whether you've inherited the same vulnerability before a fall reveals it.
Taking Long-Term Steroids
Chronic prednisone or dexamethasone weakens hip bone density within months. Tracking the score helps decide if you need bone-protective treatment.
Already Lifting and Want Proof It's Working
High-intensity resistance training can genuinely raise hip bone density. Serial scans show whether your program is moving the number.

About BMD T Score (Right Femoral Neck)

One in two women and one in four men over fifty will break a bone because of weak bones, and the hip is the break that changes everything. A hip fracture can end independence, mobility, and sometimes life itself. The right femoral neck T-score is the number that tells you, years in advance, whether your hip is heading in that direction.

This is a measurement of bone strength at the narrow part of your upper thigh bone where it meets the hip joint, the exact spot where most hip fractures occur. It compares your bone density to that of a healthy 20 to 29 year old, giving you a single number that doctors, guidelines, and large studies have used for decades to decide who needs treatment.

How the Score Works

Your bone density is measured by a low-dose X-ray scan called DXA (dual-energy X-ray absorptiometry). The result is converted into a T-score by counting how many standard deviations your density sits above or below the peak density of a young adult. A score of zero means you match the young adult average. Negative numbers mean your bones are less dense; positive numbers mean denser.

World Health Organization thresholds, adopted globally and used by major labs and guidelines, split T-scores into three categories: normal, low bone mass (called osteopenia), and osteoporosis. These cutoffs apply to the right femoral neck just as they do to the left hip or lumbar spine.

Hip Fracture Risk

This is the headline finding. In a study of about 273,000 Asian women, each one-unit drop in hip T-score roughly doubled the risk of hip fracture. In a UK cohort of postmenopausal women followed for ten years, femoral neck DXA was a stronger predictor of hip fracture than measurements taken at the spine or wrist, with risk rising in a non-linear, accelerating way as scores fell.

What this means for you: the femoral neck is the single most informative bone site for predicting whether you will break your hip. A score of minus 2.5 is not a minor blip on a report. It signals roughly four times the fracture rate of someone with normal bone density.

Major Osteoporotic Fractures

Beyond the hip, lower femoral neck T-scores predict spine, wrist, shoulder, and other fragility fractures. A study of more than 42,000 adults found that the relationship between femoral neck T-score and major fracture risk was essentially identical in people with and without type 2 diabetes. The same threshold meant the same risk, regardless of diabetes status.

Many fractures still happen in people whose scores fall in the osteopenia range, not just full osteoporosis. In the BoMIC study of more than 7,000 older adults, most incident fractures occurred in people with T-scores above minus 2.5. This is why doctors do not treat the T-score in isolation but combine it with age, prior fractures, and other risk factors using tools like FRAX.

Beyond the Bones

Lower femoral neck T-scores also flag broader health risks. In a study of about 12,700 Asian women, T-score-defined osteoporosis roughly doubled the risk of atherosclerotic cardiovascular disease compared to normal bone density. In acute ischemic stroke patients, osteoporosis at the right femoral neck nearly tripled the odds of poor functional recovery at three months, with an odds ratio of 2.97 even after adjusting for age, sex, and stroke severity.

Bone is not isolated from the rest of your body. A low T-score often coincides with systemic processes (chronic inflammation, hormonal shifts, vascular aging) that affect more than the skeleton. Treating it as a hip-only number misses the larger signal.

Reference Ranges

These cutoffs come from World Health Organization criteria based on white young adult reference data and are adopted by major guideline bodies including the National Bone Health Alliance and the International Society for Clinical Densitometry. Different ethnic groups may benefit from slightly adjusted thresholds (research in older East Asians suggests cutoffs closer to minus 2.7 in some populations), and your specific DXA machine and lab may use slightly different references. Compare results from the same scanner over time for the most meaningful trend.

TierT-Score RangeWhat It Suggests
NormalAbove minus 1.0Bone density comparable to a healthy young adult. Lowest fracture risk.
Osteopenia (low bone mass)Minus 1.0 to minus 2.5Bone density below young adult peak. Fracture rate roughly 1.8 times normal.
OsteoporosisMinus 2.5 or belowSignificantly weakened bone. Hip and major fracture rate roughly 4 times normal.
Treatment targetMinus 2.0 or aboveLong-term denosumab trials suggest fracture risk plateaus once hip T-scores reach this range.

Note: Compare your results within the same lab and same scanner over time for the most meaningful trend. Small differences between machines can shift T-scores by 0.1 to 0.3 without any real change in your bones.

Right Versus Left Hip

Most DXA reports include measurements from both hips, the spine, and sometimes the forearm. Right and left femoral neck T-scores are highly correlated and usually agree on the diagnosis. In a study of more than 2,300 women, measuring both sides only changed the classification in a small minority of cases.

That said, using the lowest T-score from all measured sites (spine plus both hips) catches more cases of osteoporosis than relying on a single site. If your right femoral neck is normal but your spine or left hip is in osteoporosis range, the lowest number wins for diagnosis. Do not assume a normal right hip means your skeleton is in the clear.

Tracking Your Trend

A single T-score is a snapshot. What matters more is the direction of travel. Bone density changes slowly, so meaningful change usually takes one to two years to detect. The right femoral neck has a known measurement variability of roughly 1 to 2 percent on the same machine, meaning small changes can be noise rather than signal.

For tracking: get a baseline scan, retest in one to two years if you are at risk or starting treatment, and at least every two years thereafter. If you are on osteoporosis medication, repeat scans confirm whether the drug is working. If you are perimenopausal or just starting hormone changes, more frequent monitoring helps catch accelerated loss early. People with normal density and no risk factors can often wait longer, but having an early baseline gives you something to compare against decades later.

What to Do With an Abnormal Result

If your T-score lands in the osteopenia range (minus 1.0 to minus 2.5), the next step is to calculate your 10-year fracture probability using the FRAX tool, which combines your T-score with age, weight, prior fractures, smoking, and other clinical factors. A FRAX score above 3 percent for hip or 20 percent for major fractures usually triggers treatment consideration.

If your T-score is minus 2.5 or below, treatment is typically indicated regardless of FRAX. Companion workup should include vitamin D (25-hydroxy), calcium, parathyroid hormone (PTH), thyroid function (TSH), and a basic metabolic panel to look for secondary causes. In men or younger women with unexpectedly low bone density, testosterone (for men) or sex hormone testing and a celiac screen are reasonable additions. If your scores are dropping fast despite good lifestyle measures, an endocrinologist or rheumatologist can evaluate for less common causes including Cushing syndrome, multiple myeloma, or hyperparathyroidism.

What Moves This Biomarker

Evidence-backed interventions that affect your BMD T Score (Right Femoral Neck) level

Increase
Take a bisphosphonate (alendronate, risedronate, zoledronate)
These are the most widely prescribed bone-building drugs and the first-line treatment for osteoporosis. A systematic review and network meta-analysis in postmenopausal women found bisphosphonates significantly increase femoral neck and total hip BMD and reduce both vertebral and hip fractures. Zoledronate and pamidronate produced the largest gains.
MedicationStrong Evidence
Increase
Take denosumab (Prolia, twice-yearly injection)
Over 10 years of denosumab treatment, total hip and femoral neck T-scores rose progressively, and higher T-scores translated directly into lower nonvertebral fracture risk. Risk plateaued around a hip T-score between minus 2.0 and minus 1.5, supporting that range as a practical treatment target. For people with osteoporosis, this is one of the most consistent ways to push femoral neck T-scores out of the high-risk range.
MedicationStrong Evidence
Increase
Take romosozumab (Evenity) for 12 months
In a phase 3 trial of postmenopausal women transitioning from oral bisphosphonates, romosozumab produced larger gains in hip and femoral neck BMD than teriparatide. In a separate trial, 24 months of romosozumab followed by 12 months of denosumab increased BMD in postmenopausal women with low bone mass. This is typically reserved for severe osteoporosis or fracture history.
MedicationStrong Evidence
Increase
Take teriparatide or abaloparatide (daily injection)
These bone-building (anabolic) drugs stimulate new bone formation rather than slowing breakdown. A systematic review found teriparatide and abaloparatide effectively improve BMD and reduce fracture incidence in men with osteoporosis. Combination with denosumab produces larger BMD gains than teriparatide alone, but long-term fracture data are still emerging.
MedicationStrong Evidence
Decrease
Take long-term oral corticosteroids (prednisone, dexamethasone)
Long-term glucocorticoid use, such as for myasthenia gravis or autoimmune disease, lowers femoral neck T-scores and increases fracture risk. Higher cumulative doses correlate with lower bone mass. Cushing syndrome (excess cortisol) produces the same pattern, and surgical cure can partially reverse it. If you must take steroids, bone-protective therapy is often added alongside.
MedicationStrong Evidence
Increase
Do high-intensity resistance and impact training
The LIFTMOR trial randomized 101 postmenopausal women with low bone mass to twice-weekly high-intensity resistance and impact training or a low-intensity home program. The high-intensity group significantly improved femoral neck and lumbar spine BMD and physical function, with no adverse events. This is the strongest exercise evidence for genuinely changing bone density at the hip.
ExerciseModerate Evidence
Increase
Do progressive high-load resistance training
A meta-analysis of high-load resistance training in osteoporosis and osteopenia found significant increases in BMD at the femoral neck and lumbar spine. A separate trial in postmenopausal women with osteopenia confirmed that high-intensity protocols outperform low-intensity training for improving femoral neck bone indicators.
ExerciseModerate Evidence
Increase
Take menopausal hormone therapy (estrogen with or without progesterone)
A 2-year randomized trial in Chinese postmenopausal women found standard-dose hormone therapy significantly increased BMD compared to placebo. A separate trial in oligo-amenorrheic athletes showed transdermal estradiol over 12 months improved BMD versus an ethinyl estradiol contraceptive pill. Estrogen preserves bone by slowing the bone loss that follows menopause.
MedicationModerate Evidence
Decrease
Take tenofovir disoproxil fumarate (TDF) for HIV
Over 96 weeks in Chinese patients with HIV, TDF-containing antiretroviral therapy caused roughly 4 percent BMD loss at the hip and femoral neck compared to non-TDF regimens. The bone loss reflects a real drug effect on bone metabolism, not a measurement artifact. Switching to tenofovir alafenamide or other regimens can mitigate this.
MedicationModerate Evidence
Increase
Address low body weight or malnutrition
In rheumatoid arthritis patients, a lower Geriatric Nutritional Risk Index (GNRI) was associated with lower femoral neck BMD. Improving nutritional status correlates with better bone density. Low body weight is one of the strongest non-genetic predictors of low femoral neck T-scores.
LifestyleModerate Evidence
Increase
Take calcium and vitamin D together daily
A meta-analysis of randomized trials found combined calcium and vitamin D supplementation significantly increases BMD and reduces hip fracture risk in postmenopausal women. A separate analysis showed pelvic BMD improvements and correction of vitamin D deficiency, though clinical fracture reduction was less consistent. Effect sizes are smaller than with prescription drugs but matter for prevention.
SupplementModest Evidence

Frequently Asked Questions

References

24 studies
  1. Lee SB, Cho a, Butcher K, Kim TW, Ryu S, Kim YIInternational Journal of Stroke2013
  2. Van Hulten V, Driessen JHM, Andersen S, Kvist a, Viggers R, Bliuc D, Center JR, Brouwers MCJG, Vestergaard P, Van Den Bergh JPDiabetes, Obesity and Metabolism2024
  3. Petley G, Taylor P, Murrills a, Dennison E, Pearson G, Cooper COsteoporosis International2000
  4. Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-hughes B, Favus MJ, Harris ST, Jan De Beur SM, Khosla S, Lane NE, Lindsay R, Nana AD, Orwoll ES, Saag K, Silverman S, Watts NBOsteoporosis International2014